Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
Titel:
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
Auteur:
Hauschild, Axel Ascierto, Paolo A. Schadendorf, Dirk Grob, Jean Jacques Ribas, Antoni Kiecker, Felix Dutriaux, Caroline Demidov, Lev V. Lebbé, Céleste Rutkowski, Piotr Blank, Christian U. Gutzmer, Ralf Millward, Michael Kefford, Richard Haas, Tomas D'Amelio Jr., Anthony Gasal, Eduard Mookerjee, Bijoyesh Chapman, Paul B.